About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Study of Dasatinib in Patients With Advanced Solid Tumors

Study of Dasatinib in Patients With Advanced Solid Tumors

NCT00162214·4 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Bristol-Myers Squibb

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

ECOG status 0-2
Advanced or metastatic disease, unresponsive to standard treatment (or no standard treatment exists)
Biopsy pretreatment
Adequate bone marrow, liver and kidney function

You may not be if

Serious cardiovascular disease
Bleeding disorders
Gastrointestinal (GI) tract disease
Platelet inhibitors
H2 blockers, proton pump inhibitors

The record

StatusTerminated

PhasePhase 1

Taking part60

StartedAug 2005

UpdatedApr 14, 2011

Conditions

Where4

Lee S. Rosen M.D.
Santa Monica, California, United States
H. Lee Moffitt Cancer Center
Tampa, Florida, United States
Sarah Cannon Research Institute
Nashville, Tennessee, United States